Identification of Selective α-Glucosidase Inhibitors via Virtual Screening with Machine Learning
Fengyu Guo1, Jiali Shi1, Wenhua Jin1
1Department of Nutrition and Health, China Agricultural University, Beijing 100083, China.
None:
Given the limitations of clinical and potent natural α-glucosidase inhibitors, novel selective inhibitors are urgently needed. To accelerate discovery, we employed machine learning-integrated virtual screening to rapidly evaluate a library of 100 K+ compounds, identifying a series of selective α-glucosidase inhibitors. Activity validation demonstrated that these inhibitors exhibit significantly enhanced selectivity and potency compared to the positive control acarbose. Mechanistic studies through inhibition kinetics and fluorescence quenching revealed their improved inhibitory profile. Molecular docking indicates that key interactions-hydrogen bonding or salt bridges with the catalytic residue ASP526-strengthen binding within the active site. These interactions competitively obstruct enzyme-substrate binding, thereby amplifying inhibition. In vitro and in vivo starch digestion assays further corroborated these findings.
More Related Videos
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Drug Discovery: Overview
